Lucas Oxenford is an associate in the Litigation group. While earning his J.D. from University of Chicago Law School, he was comments editor for the Chicago Journal of International Law and served as president of the Intellectual Property Law Society.
Lucas graduated from University of Washington with a B.S. in Bioengineering and minors in Applied Mathematics and Chemistry. There, he received a Mary Gates Research Scholarship for his work in the UW Heart and Muscle Mechanics Laboratory, studying the effects of gene mutations on muscle structure and function. He also worked at Pacific Northwest National Laboratory, where he operated a particle accelerator to test the composition and strength of thin films.
- Alector v. Asa Abeliovich, M.D., Ph.D. (JAMS arbitration). Represented prominent neuroscientist and drug developer Asa Abeliovich, the founder and CEO of Prevail Therapeutics, a company developing gene therapies for patients suffering from neurodegenerative diseases, in a trade secret arbitration proceeding. The case involved allegations that Prevail’s work was based on Alector’s alleged trade secrets, for which Alector sought relief in the form of substantial monetary damages as well as ownership rights to Prevail’s intellectual property estate. After a two-week arbitration hearing, the arbitrator rejected all of the principal claims against Dr. Abeliovich, including all claims alleging misappropriation or misuse of trade secrets and confidential information.
- Nike Inc. v. Skechers U.S.A., Inc. (C.D. Cal.). Representing Skechers in multiple design patent and utility patent infringement lawsuits involving athletic shoes.
University of Chicago Law School (J.D., 2019); Comments editor, Chicago Journal of International Law
University of Washington (B.S. Bioengineering; minors, Applied Mathematics and Chemistry, 2015); Mary Gates Research Scholar